title: Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment.
authors.forename: A
authors.initials: A
authors.lastname: Bush
authors.forename: M E
authors.initials: ME
authors.lastname: Hodson
authors.forename: D M
authors.initials: DM
authors.lastname: Geddes
authors.forename: M
authors.initials: M
authors.lastname: Rosenthal
authors.forename: R
authors.initials: R
authors.lastname: Dinwiddie
authors.forename: C
authors.initials: C
authors.lastname: Wallis
authors.forename: D E
authors.initials: DE
authors.lastname: Stableforth
authors.forename: S P
authors.initials: SP
authors.lastname: Conway
authors.forename: J M
authors.initials: JM
authors.lastname: Littlewood
mesh_terms: D003550:Cystic Fibrosis / Q000188:drug therapy*; D003850:Deoxyribonuclease I / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I